2024 Dec 20
21:51

Discloseable Transaction

Discloseable Transactions - Proposed Share Repurchase(s) and Proposed Adoption of Share Award Scheme by a Listed Subsidiary

00882 - TIANJIN DEV

2024 Dec 11
17:51

Loan Agreement with Specific Performance Covenant

Announcement Pursuant to Rule 13.18 of the Listing Rules

00882 - TIANJIN DEV

2024 Dec 05
06:07

Notice of EGM/SGM / Closure of Books or Change of Book Closure Period

Notice of Extraordinary General Meeting

00882 - TIANJIN DEV

2024 Dec 05
06:06

Proxy Forms

Form of Proxy for Extraordinary General Meeting to be held on 30 December 2024

00882 - TIANJIN DEV

2024 Dec 05
06:04

Documents on Display

Renewal of Existing Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd. and Notice of Extraordinary General Meeting

00882 - TIANJIN DEV

2024 Nov 26
06:03

Overseas Regulatory Announcement - Other

An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

00882 - TIANJIN DEV

2024 Nov 15
18:11

Continuing Connected Transaction

Renewal of Existing Continuing Connected Transactions and Entering Into of New Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd.

00882 - TIANJIN DEV

2024 Nov 15
17:48

Continuing Connected Transaction

Renewal of Existing Continuing Connected Transactions with Tianjin Pharmaceutical Group Co., Ltd.

00882 - TIANJIN DEV

2024 Oct 30
06:02

Inside Information / Results of a Subsidiary

Unaudited Financial Results for the nine months ended 30 September 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.

00882 - TIANJIN DEV

2024 Sep 26
20:11

Discloseable Transaction

Discloseable Transaction - Subscription of Wealth Management Product

00882 - TIANJIN DEV